India — Macaroni and Noodle Products

← back to leaderboard

India received 171 FDA import refusals in Macaroni and Noodle Products between 2023-Q4 and 2026-Q3. Volume peaked at 43 in 2024-Q4, with the trend falling sharply year-on-year. The most-cited issues are filthy, nutrit lbl, and list ingre. No trade baseline is published for this commodity from India, so no per-$1B rate is shown here.

Of these, 150 were hazard refusals and 21 were paperwork refusals.

Exporting from India? Get an email when shipments from India are refused at the US border — before your buyers ask.

Quarterly rejections, last 12 quarters

9 2023-Q4 2023-Q4: 9 4 2024-Q1 2024-Q1: 4 10 2024-Q2 2024-Q2: 10 16 2024-Q3 2024-Q3: 16 43 2024-Q4 2024-Q4: 43 11 2025-Q1 2025-Q1: 11 20 2025-Q2 2025-Q2: 20 20 2025-Q3 2025-Q3: 20 6 2025-Q4 2025-Q4: 6 17 2026-Q1 2026-Q1: 17 9 2026-Q2 2026-Q2: 9 6 2026-Q3 2026-Q3: 6

By commodity, last 156 weeks

Commodity Rejections Per $1B US imports Most-cited hazard
Noodles-Pasta 172 4,280 filthy

Recent rejections